Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
National Reference Laboratory is a UAE-based clinical diagnostics and reference laboratory company focused on delivering routine and specialized laboratory testing services across the UAE and GCC. The company operates as an M42 partner and has expanded from a single standalone lab into a network of 12 state-of-the-art facilities, serving the Mubadala Health network and more than 250 external clients. Its menu includes more than 5,000 assays spanning clinical pathology, microbiology, genomics, HLA typing, newborn screening, oncology, and rare disease diagnostics, alongside laboratory management and point-of-care testing solutions. NRL is a healthcare services company rather than a therapeutics developer, so it does not have a traditional drug pipeline; its business centers on commercial diagnostic testing infrastructure, operational laboratory management, and advanced precision-medicine testing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on National Reference Laboratory.